Ironwood posts positive 2019 adjusted EBITDA from continuing operations guidance
– Ironwood launches as GI-focused healthcare company following separation of Cyclerion Therapeutics on April 1, 2019 – – First quarter…
Pharmaceuticals, Biotechnology and Life Sciences
– Ironwood launches as GI-focused healthcare company following separation of Cyclerion Therapeutics on April 1, 2019 – – First quarter…
Enrolled first patient in National Cancer Institute (NCI)-sponsoredPhase 3 trial of uproleselan in older adults with previously untreatedacute myeloid leukemia (AML)
DUBLIN–(BUSINESS WIRE)–The “Smoothened Homolog (Protein Gx or SMO) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Hypoglycemia – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest pipeline guide…
DUBLIN–(BUSINESS WIRE)–The “Alzheimer’s Disease: Pipeline Review, Developer Landscape and Competitive Insights” report has been added to ResearchAndMarkets.com’s offering. Alzheimer’s disease…
DUBLIN–(BUSINESS WIRE)–The “Chronic Kidney Disease: Global Markets and Technologies Through 2023” report has been added to ResearchAndMarkets.com’s offering. The focus…
DUBLIN–(BUSINESS WIRE)–The “Post-Operative Pain – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical…
Company to focus on benefits of CBD for non-addictive pain management and opioid, alcohol addiction recovery NEWPORT BEACH, Calif.–(BUSINESS WIRE)–lt;a…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of…
Optivida will leverage Frelii’s proprietary DNAKit Packages™ to ensure Optivida customers can realize the optimalbenefits of which specific Optivida products best suit their unique DNAprofile.